THE ITPA GENOTYPE CORRELATES WITH HEMOLYTIC ANEMIA AND OUTCOME AFTER TREATMENT WITH PEGYLATED-INTERFERON AND RIBAVIRIN IN GENOTYPE 1B CHRONIC HEPATITIS C

被引：0
|
作者：
Kurosaki, M. [1 ]
Tanaka, K. [1 ]
Suzuki, Y. [1 ]
Hoshioka, Y. [1 ]
Tamaki, N. [1 ]
Kato, T. [1 ]
Yasui, Y. [1 ]
Hosokawa, T. [1 ]
Ueda, K. [1 ]
Tsuchiya, K. [1 ]
Kuzuya, T. [1 ]
Nakanishi, H. [1 ]
Itakura, J. [1 ]
Takahashi, Y. [1 ]
Asahina, Y. [1 ]
Mizokami, M. [2 ]
Tanaka, Y. [3 ]
Sakamoto, N. [4 ]
Enomoto, N. [5 ]
Izumi, N. [1 ]
机构：
[1] Musashino Red Cross Hosp, Tokyo, Japan
[2] Japan Konodai Hosp, Int Med Ctr, Chiba, Japan
[3] Nagoya City Univ, Grad Sch Med Sci, Nagoya, Aichi, Japan
[4] Tokyo Med & Dent Univ, Tokyo, Japan
[5] Univ Yamanashi, Yamanashi, Japan
来源：
JOURNAL OF HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
10.1016/S0168-8278(11)60443-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
441
引用
收藏
页码：S179 / S179
页数：1
相关论文
共 50 条
  • [1] PREDICTION MODEL OF ANEMIA USING ITPA GENOTYPE IDENTIFIES PATIENTS AT HIGH RISK OF ANEMIA AND TREATMENT FAILURE WITH PEGYLATED-INTERFERON PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C
    Kurosaki, M.
    Itakura, J.
    Tsuchiya, K.
    Nakanishi, H.
    Asahina, Y.
    Mizokami, M.
    Tanaka, Y.
    Izumi, N.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S445 - S445
  • [2] Model incorporating the ITPA genotype identifies patients at high risk of anemia and treatment failure with pegylated-interferon plus ribavirin therapy for chronic hepatitis C
    Kurosaki, Masayuki
    Tanaka, Yasuhito
    Nishida, Nao
    Sakamoto, Naoya
    Enomoto, Nobuyuki
    Matsuura, Kentaro
    Asahina, Yasuhiro
    Nakagawa, Mina
    Watanabe, Mamoru
    Sakamoto, Minoru
    Maekawa, Shinya
    Tokunaga, Katsushi
    Mizokami, Masashi
    Izumi, Namiki
    JOURNAL OF MEDICAL VIROLOGY, 2013, 85 (03) : 449 - 458
  • [3] RESPONSE FACTORS TO PEGYLATED INTERFERON-ALFA/RIBAVIRIN TREATMENT IN CHRONIC HEPATITIS C PATIENTS GENOTYPE 1B
    Jovanovic-Cupic, Snezana
    Glisic, S.
    Stanojevic, M.
    Vasiljevic, N.
    Bojic-Milinovic, T.
    Bozovic, A.
    Dimitrijevic, B.
    ARCHIVES OF BIOLOGICAL SCIENCES, 2014, 66 (01) : 193 - 201
  • [4] Merimepodib, Pegylated Interferon, and Ribavirin in Genotype 1 Chronic Hepatitis C Pegylated Interferon and Ribavirin Nonresponders
    Rustgi, Vinod K.
    Lee, William M.
    Lawitz, Eric
    Gordon, Stuart C.
    Afdhal, Nezam
    Poordad, Fred
    Bonkovsky, Herbert L.
    Bengtsson, Leif
    Chandorkar, Gurudatt
    Harding, Matthew
    McNair, Lindsay
    Aalyson, Molly
    Alam, John
    Kauffman, Robert
    Gharakhanian, Shahin
    McHutchison, John G.
    HEPATOLOGY, 2009, 50 (06) : 1719 - 1726
  • [5] A RETROSPECTIVE COMPARATIVE STUDY OF PEGYLATED INTERFERON AND RIBAVIRIN FOR THE TREATMENT OF CHRONIC HEPATITIS C GENOTYPE 6 AND GENOTYPE 1
    Tsang, Owen T.
    Zee, Janpaul
    Chan, Jacky
    Li, Reggie S.
    Lai, Jak Yiu
    Lai, Thomas S.
    HEPATOLOGY, 2008, 48 (04) : 884A - 884A
  • [6] HCV core antigen is a useful predictor during pegylated-interferon/ribavirin therapy in patients with hepatitis C virus genotype 1b
    Fan, Zhijuan
    Liu, Junfeng
    Wang, Fengmei
    Liu, Jingmin
    Ding, Xian
    Liu, Shuye
    MEDICINE, 2019, 98 (10)
  • [7] PREDICTION MODEL OF RIBAVIRIN-INDUCED ANEMIA INCORPORATING ITPA GENOTYPE COULD IDENTIFY CHRONIC HEPATITIS C PATIENTS AT HIGH RISK OF RELAPSE AMONG VIROLOGICAL RESPONDERS TO PEGYLATED-INTERFERON AND RIBAVIRIN
    Kurosaki, Masayuki
    Itakura, Jun
    Yasui, Yutaka
    Tsuchiya, Kaoru
    Nakanishi, Hiroyuki
    Takahashi, Yuka
    Asahina, Yasuhiro
    Tanaka, Yasuhito
    Mizokami, Masashi
    Sakamoto, Naoya
    Enomoto, Nobuyuki
    Izumi, Namiki
    HEPATOLOGY, 2011, 54 : 823A - 823A
  • [8] Effectiveness of sofosbuvir/pegylated-interferon plus ribavirin in treatment of hepatitis C virus genotype 4 patients
    Abdel-Moneim, Adel
    Abood, Alaa
    Abdel-Gabaar, Mohamed
    Zanaty, Mohamed I.
    Ramadan, Mohamed
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2018, 4 (03) : 191 - 196
  • [9] Pegylated interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C genotype
    Hasan, F
    Asker, H
    Al-Khaldi, J
    Siddique, I
    Owaid, SF
    Al-Ajmi, M
    Al-Nakib, B
    HEPATOLOGY, 2003, 38 (04) : 629A - 629A
  • [10] Prediction of response to pegylated interferon/ribavirin combination therapy for chronic hepatitis C genotype 1b and high viral load
    Soo Ryang Kim
    Ahmed El-Shamy
    Susumu Imoto
    Ke Ih Kim
    Yoshi-hiro Ide
    Lin Deng
    Ikuo Shoji
    Yasuhito Tanaka
    Yutaka Hasegawa
    Mitsuhiro Ota
    Hak Hotta
    Journal of Gastroenterology, 2012, 47 : 1143 - 1151
12345